Valneva Austria GmbH
🇦🇹Austria
Virological Response Study of the HCV Vaccine IC41
Phase 2
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- Biological: IC41
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2014-02-11
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 71
- Registration Number
- NCT00601770
- Locations
- 🇵🇱
Prof. Dr. Andrzej Gladszy, Wroclaw, Poland
🇷🇴Dr. Adriana Hristea, Bucharest, Romania
🇷🇴Prof. Dr. Carol Stanciu, Iasi, Romania
Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine
Phase 2
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- Biological: IC41
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2012-10-19
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 66
- Registration Number
- NCT00602784
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: IC51
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 349
- Registration Number
- NCT00595270
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: IC51Biological: HAVRIXOther: Placebo
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 192
- Registration Number
- NCT00596271
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: IC51
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 374
- Registration Number
- NCT00595790
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: Japanese Encephalitis purified inactivated vaccine
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 389
- Registration Number
- NCT00595465
- Locations
- 🇩🇪
Berliner Zentrum Reise- und Tropenmedizin, Berlin, Germany
🇦🇹Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie, Vienna, Austria
🇩🇪Klinik und Poliklinik für Innere Medizin der Universität Rostock, Rostock, Germany
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: IC51
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 198
- Registration Number
- NCT00595309
- Locations
- 🇦🇹
Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie, Vienna, Austria
🇦🇹Zentrum für Reisemedizin, Dependance für klinische Studien, Vienna, Austria
🇩🇪Berliner Zentrum Reise- und Tropenmedizin, Berlin, Germany
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: IC51
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 639
- Registration Number
- NCT00594958
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Completed
- Conditions
- Japanese Encephalitis
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- Valneva Austria GmbH
- Target Recruit Count
- 3258
- Registration Number
- NCT00596102
© Copyright 2025. All Rights Reserved by MedPath